SecBot SecBot
8-K ·Filed Aug 18, 2026

ARXS

Arxis, Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed2mo ago SEC0001193125-26-354774
8-K material event: Items 2.01
Actionable Insight • Neutral

The deal closure removes overhang but the stock-for-stock structure and 12x EBITDA multiple on forward estimates provide no immediate catalyst. Monitor next quarterly report for Omnetics revenue contribution and margin profile.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
ARXS ▼ -12.24% at T+20d
NEUTRAL call -12.24% · α vs SPY -11.25% · entry $56.56 → $49.64
Next anchor: T+60d in 15d
Latest observation: T+47 -15.79% FF3 residual α
Entry = T+0 close
Aug 18, 2026
via day close
T+1d
-1.50%
call -1.50% · α -1.71%
$55.71
settled 2mo ago
T+5d
-6.33%
call -6.33% · α -6.13%
$52.98
settled 2mo ago
T+20d
-12.24%
call -12.24% · α -11.25%
$49.64
settled 6w ago
T+60d
Pending
in 15d

Price Chart

Loading chart...

Executive Summary

Arxis completed its all-stock acquisition of Omnetics Connector Corporation for an enterprise value of $770 million, issuing 13,351,964 shares (approximately 3.1% dilution) to former Omnetics shareholders. The deal closed on August 17, 2026, and combined with the prior MagCanica acquisition at a ~12x FY27 estimated adjusted EBITDA multiple.

Key Financial Metrics

Dilution
3.1%

Key Facts

  • Arxis completed the acquisition of Omnetics Connector Corporation for an enterprise value of $770 million.
  • Arxis issued 13,351,964 shares of Class A common stock (approximately 3.1% of total common stock) as consideration.
  • The shares are subject to lockup provisions.
  • The combined purchase price multiple with the MagCanica acquisition is approximately 12x FY27 estimated adjusted EBITDA.
  • Omnetics will operate within Arxis' Electronic Components Segment.

Financial Impact

$770 million enterprise value acquisition funded with 13,351,964 shares (~3.1% dilution)

dilutionenterprise valueEBITDA multiple

Risk Factors

  • Integration risks for Omnetics and MagCanica may delay expected synergies.
  • The 12x FY27 estimated adjusted EBITDA multiple relies on forward projections that may not materialize.

Market Snapshot

Exchange
Nasdaq
Analyst Consensus
88% bullish (16 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-354774
Document: arxs-ex99_1.htm0001193125-26-354774
Document: 0001193125-26-354774-index-headers.html0001193125-26-354774
Document: 0001193125-26-354774-index.html0001193125-26-354774
Document: 0001193125-26-354774.txt0001193125-26-354774
14 reports for ARXS
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +25.65%Jun 2, 2026
Filters
Rows
Reports for ARXS — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
EFFECT
NEUTRAL ★ 5/10
$51.72awaiting T+60—$52.73 (+1.95%)
Oct 15, 2026
11d ago
Press Release
NEUTRAL ★ 1/10
$54.10awaiting T+60—$52.73 (−2.53%)
Oct 13, 2026
13d ago
S-1
NEUTRAL ★ 4/10
$49.91awaiting T+60—$52.73 (+5.65%)
Sep 21, 2026
5w ago
SC 13G
NEUTRAL ★ 3/10
$51.21awaiting T+60—$52.73 (+2.97%)
Aug 18, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$56.56awaiting T+60—$52.73 (−6.77%)
Aug 18, 2026
9w ago
Press Release
MIXED ★ 6/10
$56.56awaiting T+60—$52.73 (−6.77%)
Aug 15, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$57.60awaiting T+60—$52.73 (−8.45%)
Jun 2, 2026
20w ago
8-K
BULLISH ★ 7/10
$42.84 $53.83▲ +25.65%▲ +24.54%$52.73 (+23.09%)
May 28, 2026
21w ago
8-K
BULLISH ★ 7/10
$46.83 $53.26▲ +13.73%▲ +12.00%$52.73 (+12.60%)
Apr 17, 2026
27w ago
8-K
NEUTRAL ★ 5/10
$37.65 $41.55▲ +10.36%▲ +3.58%$52.73 (+40.05%)
Showing 10 of 14

US Market Status

Market Closed — Opens Wed (11h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 18, 2026